Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO
Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market yesterday under the symbol “DICE”.
Read moreBiopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market yesterday under the symbol “DICE”.
Read more